Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
Jim Cramer on the market’s ‘remarkable’ rally — and what to watch ahead
CNBC’s Jim Cramer on Friday laid out his recreation plan for the week forward after what he referred to as…
Tovala Family Meals Review: Good Food, Lots of Salt
A garlic-herb salmon with risotto was most likely the most effective among the many household meals I attempted. The chopped…
The Best After-Christmas Deals on Gear We’ve Tested (2025)
After-Christmas offers are a superb option to redeem any reward playing cards or money you bought for Christmas. You should…